[Federal Register Volume 67, Number 210 (Wednesday, October 30, 2002)]
[Notices]
[Pages 66161-66162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-27551]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-03-07]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404)498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Seleda Perryman, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Intimate Partner Violence Screening: A Randomized 
Trial Comparing Computerized Questionnaires and Nursing Staff 
Interviews--New--National Center for Injury Prevention and Control 
(NCIPC), Centers for Disease Control and Prevention (CDC).
    The purpose of this project is to determine effective ways to 
screen for intimate partner violence (IPV) in clinical settings. The 
project will compare the sensitivity, specificity and cost of screening 
for intimate partner violence (IPV) through a randomized trial using 
two modes of administering the screening questionnaire. Modes to be 
compared are computer administration and face-to-face interviews by a 
nurse. Computerized screens will be of two different lengths. Three 
questions on the face-to-face interview will be identical to a short 
computer screen; a longer computer

[[Page 66162]]

screen will include those three items and will also ask additional 
questions. Thus, the evaluation can examine both mode of screening and 
content of screening questions. The screening modes will be assessed in 
a primary care clinic in Albany, New York.
    IPV is associated with a variety of physical and psychological 
problems but despite the high prevalence of IPV among patients seen in 
primary care and prenatal care, it is infrequently detected and treated 
in primary care settings. Only one in three abused women has discussed 
the abuse with her physician. Disclosure of abuse has been found to be 
associated with direct physician screening, and female IPV victims 
report that they would be willing to discuss their abuse if asked by 
their physician. Computer questionnaires hold promise for IPV screening 
of primary care patients because: (1) There are low continuing costs 
after initial setup and (2) computer questionnaires have been found 
useful for obtaining sensitive risk factor information on other topics 
(e.g., drug use, HIV risk factors).
    The U.S. Preventive Services Task Force finds ``insufficient 
evidence to recommend for or against the use of specific screening 
instruments to detect family violence'' because of the absence of 
studies demonstrating that detection and treatment of IPV improves 
physical or psychological health, or decreases IPV. This study can 
provide needed evidence about the detection of IPV, which in turn, can 
be used in studies evaluating the effectiveness of screening followed 
by appropriate treatment. There is no cost to respondent.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg.  burden/
                   Respondent                        Number of      responses/     response  (in   Total  burden
                                                    respondents     respondent        hours)        (in hours)
----------------------------------------------------------------------------------------------------------------
Patients........................................             300               2           16/60             160
Health Care Providers and Nurses................              14               7          6.4/60              10
Health Care Admitting Staff.....................              36               1           15/60               9
                                                 -----------------
    Total.......................................             350  ..............  ..............             179
----------------------------------------------------------------------------------------------------------------


    Dated: October 23, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-27551 Filed 10-29-02; 8:45 am]
BILLING CODE 4163-18-P